scholarly article | Q13442814 |
P2093 | author name string | Yan Liu | |
Min Wei | |||
Yang Jiao | |||
Chunmei Zhang | |||
Jian Shen | |||
Xianlu Zeng | |||
Sheng Zheng | |||
Shui Hao | |||
P2860 | cites work | The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46 | Q28204339 |
Platelet-fibrinogen interactions | Q28207360 | ||
Molecular basis for the relationship between thrombosis and cancer | Q34342948 | ||
Platelets and thrombin generation | Q34858543 | ||
Platelet--cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation | Q35048404 | ||
Vascular Permeability Factor, Fibrin, and the Pathogenesis of Tumor Stroma Formationa | Q35224488 | ||
Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype | Q36650343 | ||
Molecular mechanisms of platelet aggregation | Q39501606 | ||
A novel cytolysis assay using fluorescent labeling and quantitative fluorescent scanning technology | Q39513036 | ||
Experimental metastasis and primary tumor growth in mice with hemophilia A. | Q40281264 | ||
Increased metastatic potential of tumor cells in von Willebrand factor-deficient mice. | Q40331839 | ||
Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation | Q40485769 | ||
Modified heparin inhibits P-selectin-mediated cell adhesion of human colon carcinoma cells to immobilized platelets under dynamic flow conditions | Q40558058 | ||
Requirement of the integrin beta 3 subunit for carcinoma cell spreading or migration on vitronectin and fibrinogen | Q43108382 | ||
Inhibition by fibrin coagulation of lung cancer cell destruction by human interleukin-2-activated killer cells | Q44522850 | ||
Chemically modified heparin inhibits the in vitro adhesion of nonsmall cell lung cancer cells to P-selectin. | Q51811829 | ||
Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. | Q55039060 | ||
P433 | issue | 5 | |
P921 | main subject | cytotoxicity | Q246181 |
P304 | page(s) | 859-865 | |
P577 | publication date | 2009-03-11 | |
P1433 | published in | Cancer Science | Q326125 |
P1476 | title | Platelets and fibrinogen facilitate each other in protecting tumor cells from natural killer cytotoxicity | |
P478 | volume | 100 |
Q33702344 | A novel blood tool of cancer prognosis in esophageal squamous cell carcinoma: the Fibrinogen/Albumin Ratio |
Q34870640 | A novel role for platelet secretion in angiogenesis: mediating bone marrow-derived cell mobilization and homing. |
Q41439920 | A retrospective discussion of the prognostic value of combining prothrombin time(PT) and fibrinogen(Fbg) in patients with Hepatocellular carcinoma |
Q47608153 | Association between plasma fibrinogen and survival in patients with small-cell lung carcinoma |
Q92651155 | Association of Preoperative Plasma D-dimmer and Fibrinogen and Renal Cell Carcinoma Outcome |
Q35995399 | Chemically modified heparins inhibit fibrinogen-bridged indirect adhesion between tumor cells and platelets |
Q35808697 | Clinical Significance of Preoperative Thrombin Time in Patients with Esophageal Squamous Cell Carcinoma following Surgical Resection |
Q37592903 | Clinical and Prognostic Effect of Plasma Fibrinogen in Renal Cell Carcinoma: A Meta-Analysis. |
Q34037782 | Clinical and prognostic significance of preoperative plasma hyperfibrinogenemia in gallbladder cancer patients following surgical resection: a retrospective and in vitro study |
Q90437381 | Clinicopathological and prognostic value of preoperative plasma fibrinogen in gastric cancer patients: A meta-analysis |
Q89533630 | Combination of Preoperative Plasma Fibrinogen and Neutrophil-to-Lymphocyte Ratio (the F-NLR Score) as a Prognostic Marker of Locally Advanced Rectal Cancer Following Preoperative Chemoradiotherapy |
Q91810151 | Comparative clinical features and short-term outcomes of gastric and small intestinal gastrointestinal stromal tumours: a retrospective study |
Q33627109 | Elevated serum plasma fibrinogen is associated with advanced tumor stage and poor survival in hepatocellular carcinoma patients |
Q42872080 | Endogenous activated protein C is essential for immune-mediated cancer cell elimination from the circulation |
Q92710708 | Fibrin(ogen) in human disease: both friend and foe |
Q38628068 | Fibrinogen promotes malignant biological tumor behavior involving epithelial-mesenchymal transition via the p-AKT/p-mTOR pathway in esophageal squamous cell carcinoma |
Q90576932 | High Preoperative Plasma Fibrinogen Independently Predicts a Poor Prognosis in Patients with Nonmetastatic RCC |
Q37185806 | High plasma fibrinogen level represents an independent negative prognostic factor regarding cancer-specific, metastasis-free, as well as overall survival in a European cohort of non-metastatic renal cell carcinoma patients |
Q34598936 | Holothurian glycosaminoglycan inhibits metastasis and thrombosis via targeting of nuclear factor-κB/tissue factor/Factor Xa pathway in melanoma B16F10 cells |
Q84972389 | Hyperfibrinogenemia after preoperative chemoradiotherapy predicts poor response and poor prognosis in rectal cancer |
Q40447303 | Hyperfibrinogenemia predicts poor prognosis in patients with advanced biliary tract cancer. |
Q38259585 | Involvement of platelet-tumor cell interaction in immune evasion. Potential role of podocalyxin-like protein 1. |
Q33415986 | Living in shear: platelets protect cancer cells from shear induced damage |
Q41396133 | Low Preoperative albumin-to-globulin ratio Predict Poor Survival and Negatively Correlated with Fibrinogen in Resectable Esophageal Squamous Cell Carcinoma |
Q37723466 | Multiple roles of the coagulation protease cascade during virus infection |
Q37641616 | Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1. |
Q94475892 | Nomogram-based prediction of survival in unresectable or metastatic gastric cancer patients with good performance status who received first-line chemotherapy |
Q41016083 | Plasma fibrinogen and serum albumin levels (FA score) act as a promising prognostic indicator in non-small cell lung cancer |
Q36028749 | Platelet to lymphocyte ratio as an independent prognostic indicator for prostate cancer patients receiving androgen deprivation therapy |
Q53613478 | Platelet-derived TGF-β1 mediates the down-modulation of NKG2D expression and may be responsible for impaired natural killer (NK) cytotoxicity in women with endometriosis. |
Q92893017 | Potential prognostic factors for predicting the chemotherapeutic outcomes and prognosis of patients with metastatic colorectal cancer |
Q35940860 | Preoperative Plasma Fibrinogen Level Represents an Independent Prognostic Factor in a Chinese Cohort of Patients with Upper Tract Urothelial Carcinoma |
Q37624146 | Preoperative Plasma Fibrinogen Level as a Significant Prognostic Factor in Patients With Localized Renal Cell Carcinoma After Surgical Treatment |
Q90529421 | Preoperative circulating FPR and CCF score are promising biomarkers for predicting clinical outcome of stage II-III colorectal cancer patients |
Q92716581 | Preoperative elevated plasma fibrinogen level predicts tumor recurrence and poor prognosis in patients with hepatocellular carcinoma |
Q37707101 | Preoperative peripheral plasma fibrinogen level is an independent prognostic marker in penile cancer |
Q51107785 | Preoperative plasma fibrinogen, but not D-dimer might represent a prognostic factor in non-metastatic colorectal cancer: A prospective cohort study. |
Q45119447 | Preoperative plasma fibrinogen, platelet count and prognosis in epithelial ovarian cancer |
Q40867243 | Pretreatment plasma fibrinogen as an independent prognostic indicator of prostate cancer patients treated with androgen deprivation therapy |
Q90040672 | Pretreatment plasma fibrinogen level as a prognostic biomarker for patients with lung cancer |
Q36064973 | Prognostic Impact of Pretreatment Plasma Fibrinogen in Patients with Locally Advanced Oral and Oropharyngeal Cancer. |
Q58576764 | Prognostic Value of Plasma Fibrinogen in Lung Cancer Patients: A Meta-Analysis |
Q61806539 | Prognostic role of preoperative platelet, fibrinogen, and D-dimer levels in patients with non-small cell lung cancer: A multicenter prospective study |
Q41875980 | Prognostic scores based on the preoperative plasma fibrinogen and serum albumin level as a prognostic factor in patients with upper urinary tract urothelial carcinoma |
Q55431114 | Prognostic significance of pretreatment plasma fibrinogen in patients with hepatocellular and pancreatic carcinomas: A meta-analysis. |
Q64964774 | Prognostic significance of the combination of preoperative fibrinogen and the neutrophil-lymphocyte ratio in patients with non-small cell lung cancer following surgical resection. |
Q58798099 | Prognostic significance of the fibrinogen-to-albumin ratio in gallbladder cancer patients |
Q43112900 | Prognostic value of a novel FPR biomarker in patients with surgical stage II and III gastric cancer |
Q41298373 | Prognostic value of combined platelet, fibrinogen, neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with lung adenosquamous cancer |
Q37706180 | Prognostic value of combined preoperative fibrinogen and neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma after liver transplantation. |
Q59135332 | Prognostic value of plasma fibrinogen in hepatocellular carcinoma: a meta-analysis |
Q57034280 | Prognostic value of the fibrinogen/albumin ratio (FAR) in patients with operable soft tissue sarcoma |
Q44018149 | Serum fibrinogen is an independent prognostic factor in operable nonsmall cell lung cancer |
Q60919673 | The Fibrinogen to Mean Platelet Volume Ratio Can Predict Overall Survival of Patients with Non-Metastatic Gastric Cancer |
Q92589445 | The Prognostic Role of a Combined Fibrinogen and Neutrophil-to-Lymphocyte Ratio Score in Patients with Resectable Hepatocellular Carcinoma: A Retrospective Study |
Q61809844 | The Prognostic Value of Pretreatment Plasma Fibrinogen in Urological Cancers: A Systematic Review and Meta-analysis |
Q41727394 | The association of an elevated plasma fibrinogen level with cancer-specific and overall survival in prostate cancer patients |
Q35534333 | The clinical significance of preoperative plasma fibrinogen level and platelet count in resectable esophageal squamous cell carcinoma |
Q36642289 | siRNA-mediated silencing of integrin β3 expression inhibits the metastatic potential of B16 melanoma cells |
Search more.